share_log

Chardan Capital Maintains Buy on Ocugen, Raises Price Target to $5

Moomoo 24/7 ·  Apr 22 07:47

Chardan Capital analyst Daniil Gataulin maintains Ocugen (NASDAQ:OCGN) with a Buy and raises the price target from $4 to $5.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment